The House Energy & Commerce Subcommittee on Oversight and Investigations held its second hearing on the 340B drug program last Wednesday. Five covered entities – including RWC-340B member AIDS Resource…
Ryan White Clinics for 340B Access was a proud sponsor of the Annual 340B Coalition Summer Conference held in Washington, DC, July 10 through 12. The conference celebrated 25 years…
Our nation is winning the war against the HIV/AIDS epidemic in large part because of the hard work of RWCs and the support provided by the 340B program. Our 340B…
The White House Office of National AIDS Policy, HHS Office of HIV/AIDS and Infectious Disease Policy, and HHS Office of Minority Health hosted a webinar-based listening session today to discuss…
Johns Hopkins Medicine published a study in the journal Clinical Infectious Diseases in May 2016 that highlights the ongoing need for the Ryan White HIV/AIDS Program and the important role it plays even in…
The Centers for Medicare and Medicaid Services (CMS) issued its long awaited regulations on Medicaid reimbursement and rebates for so-called “covered outpatient drugs” today. The rule is relevant to RWCs because drug manufacturers…
RWC-340B was invited to serve as a delegate representing the interests of Ryan White clinics participating in the 340B program at the National Leadership Summit on 340B on June 11,…
The Health Resources and Services Administration (HRSA) released its long-awaited 340B program omnibus guidance, often called the “Mega-Guidance” today. RWC-340B has reviewed the Mega-Guidance and is quite troubled by proposed changes…
August 18, 2015 marked the 25th anniversary of the passing of the Ryan White CARE Act, which marked a dramatic shift in the federal strategy for comprehensive treatment of HIV/AIDS. According…
On June 17, 2015, HRSA proposed regulations to implement elements of the Affordable Card Act that required the agency to develop guidelines for assessing civil monetary penalties on drug manufacturers…